How the latest biotech IPO targets faster, better drug development

The company's stock rose a modest 20 cents Thursday from its $15 IPO price.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.